Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303).

Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303). J Pain Symptom Manage. 2012 Feb; 43(2):205-17.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Antimetabolites, Antineoplastic
Deoxycytidine
Double-Blind Method
Female
Humans
Male
Middle Aged
Pain
Palliative Care
Pancreatic Neoplasms
Prevalence
Quality of Life
Risk Assessment
Risk Factors
Survival Analysis
Survival Rate
Treatment Outcome
United States

authors with profiles

Hedy Kindler